Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
European Heart Journal
|
November 6, 2009
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study
Peter Barlis, Evelyn Regar, Patrick W Serruys, et al.
The Lancet. Oncology
|
February 19, 2013
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A Ascierto, Dirk Schadendorf, Carola Berking, et al.
Journal of the American College of Cardiology
|
September 18, 2007
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial
Mario Togni, Stéphanie Eber, Jeannette Widmer, et al.
European Heart Journal
|
November 8, 2024
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials
Simon Wandel, Akshay S Desai, Chien-Wei Chen, et al.
Lancet (London, England)
|
September 4, 2008
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker, Patrick W Serruys, Simon Wandel, et al.
European Journal of Heart Failure
|
May 16, 2023
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy-associated genes: A subgroup analysis of the PARADIGM-HF trial
Ana Barat, Chien-Wei Chen, Natasha Patel-Murray, et al.
Lancet (London, England)
|
September 18, 2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
Christoph Stettler, Simon Wandel, Sabin Allemann, et al.
BMJ (Clinical Research Ed.)
|
September 2, 2008
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis
Christoph Stettler, Sabin Allemann, Simon Wandel, et al.
Journal of the American Heart Association
|
June 21, 2024
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic Substudy
Natasha L Patel-Murray, Luqing Zhang, Brian L Claggett, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
European Heart Journal
|
November 6, 2009
An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study
Peter Barlis, Evelyn Regar, Patrick W Serruys, et al.
The Lancet. Oncology
|
February 19, 2013
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A Ascierto, Dirk Schadendorf, Carola Berking, et al.
Journal of the American College of Cardiology
|
September 18, 2007
Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial
Mario Togni, Stéphanie Eber, Jeannette Widmer, et al.
European Heart Journal
|
November 8, 2024
Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials
Simon Wandel, Akshay S Desai, Chien-Wei Chen, et al.
Lancet (London, England)
|
September 4, 2008
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial
Stephan Windecker, Patrick W Serruys, Simon Wandel, et al.
European Journal of Heart Failure
|
May 16, 2023
Clinical characteristics of heart failure with reduced ejection fraction patients with rare pathogenic variants in dilated cardiomyopathy-associated genes: A subgroup analysis of the PARADIGM-HF trial
Ana Barat, Chien-Wei Chen, Natasha Patel-Murray, et al.
Lancet (London, England)
|
September 18, 2007
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
Christoph Stettler, Simon Wandel, Sabin Allemann, et al.
BMJ (Clinical Research Ed.)
|
September 2, 2008
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis
Christoph Stettler, Sabin Allemann, Simon Wandel, et al.
Journal of the American Heart Association
|
June 21, 2024
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic Substudy
Natasha L Patel-Murray, Luqing Zhang, Brian L Claggett, et al.
Page
of 4